Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01962792
Title Study of the Bruton's Tyrosine Kinase Inhibitor in Combination With Carfilzomib (Kyprolis), in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pharmacyclics
Indications
Therapies
Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.